HUP0400877A2 - Helyettesített imidazo[1,2-a]piridin-3-il-amid- és imidazo[1,2-a]-piridin-3-il-amin-vegyületek felhasználása gyógyszerként és eljárás a vegyületek előállítására - Google Patents
Helyettesített imidazo[1,2-a]piridin-3-il-amid- és imidazo[1,2-a]-piridin-3-il-amin-vegyületek felhasználása gyógyszerként és eljárás a vegyületek előállításáraInfo
- Publication number
- HUP0400877A2 HUP0400877A2 HU0400877A HUP0400877A HUP0400877A2 HU P0400877 A2 HUP0400877 A2 HU P0400877A2 HU 0400877 A HU0400877 A HU 0400877A HU P0400877 A HUP0400877 A HU P0400877A HU P0400877 A2 HUP0400877 A2 HU P0400877A2
- Authority
- HU
- Hungary
- Prior art keywords
- group
- carbon atom
- cycloalkyl
- alkynyl
- aryl
- Prior art date
Links
- RTOFMMILZZGGNS-UHFFFAOYSA-N imidazo[1,2-a]pyridin-3-amine Chemical class C1=CC=CN2C(N)=CN=C21 RTOFMMILZZGGNS-UHFFFAOYSA-N 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title abstract 3
- 239000003814 drug Substances 0.000 title abstract 2
- RAXXELZNTBOGNW-UHFFFAOYSA-N 1H-imidazole Chemical class C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 title 1
- 230000004770 neurodegeneration Effects 0.000 title 1
- 208000015122 neurodegenerative disease Diseases 0.000 title 1
- 125000002947 alkylene group Chemical group 0.000 abstract 12
- 229910052799 carbon Inorganic materials 0.000 abstract 12
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 abstract 10
- 125000004432 carbon atom Chemical group C* 0.000 abstract 8
- 125000003118 aryl group Chemical group 0.000 abstract 7
- 125000001072 heteroaryl group Chemical group 0.000 abstract 7
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 abstract 5
- 125000004648 C2-C8 alkenyl group Chemical group 0.000 abstract 5
- 125000004649 C2-C8 alkynyl group Chemical group 0.000 abstract 5
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 2
- 125000000623 heterocyclic group Chemical group 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
A találmány (I) általános képletű helyettesített imidazo[1,2-a]piridin-3-il-amid- és imidazo[1,2-a]piridin-3-il-amin-vegyületek ésgyógyászatilag alkalmas sóik a nitrogén-monoxid-szintáz inhibitorakénttörténő felhasználására, valamint gyógyszerek előállítására és evegyületek előállítására vonatkozik. A fenti képletben R1 jelentéseadott esetben helyettesített 1-8 szénatomos alkil-, 2-8 szénatomosalkenil-, 2-8 szénatomos alkinil-, aril- vagy heteroaril-csoport; 3-8szénatomos cikloalkil-csoport; 1-8 szénatomos alkilén-csoportonkeresztül kapcsolódó 3-8 szénatomos cikloalkil-csoport; H, F, Cl, Br,I, CN, NO2, NH2, C(=O)R5, CO2H, CO2R6, OH vagy OR7R; R2 jelentéseadott esetben helyettesített 1-8 szénatomos alkil-, 2-8 szénatomosalkenil-, 2-8 szénatomos alkinil-, aril- vagy heteroaril-csoport; 3-8szénatomos cikloalkil-csoport; 1-8 szénatomos alkilén-csoportonkeresztül kapcsolódó 3-8 szénatomos cikloalkil-csoport; H, F, Cl, Br,I, CN, NO2, NH2, C(=O)R5, CO2H, CO2R6, OH vagy OR7R; R3 jelentésehidrogénatom, C(=O)R8 vagy SO2R8; R4 jelentése hidrogénatom; adottesetben helyettesített 1-8 szénatomos alkil-, 2-8 szénatomos alkenil-,2-8 szénatomos alkinil-, aril- vagy heteroaril-csoport, amely 2 utóbbi1-8 szénatomos alkiléncsoporton keresztül is kapcsolódhat; vagy 3-8szénatomos cikloalkil- vagy 3-7 szénatomos heterociklikus-csoport,amelyek 1-8 szénatomos alkiléncsoporton keresztül is kapcsolódhatnak;R5 jelentése adott esetben helyettesített 1-8 szénatomos alkil-, 2-8szénatomos alkenil-, 2-8 szénatomos alkinil-, aril- vagy heteroaril-csoport, amely 2 utóbbi 1-8 szénatomos alkiléncsoporton keresztül iskapcsolódhat; 3-8 szénatomos cikloalkilcsoport; 1-8 szénatomosalkilén-csoporton keresztül kapcsolódó 3-8 szénatomos cikloalkil-csoport; vagy 3-7 szénatomos heterociklikus-csoport; R6 jelentéseadott esetben helyettesített 1-8 szénatomos alkil-, 2-8 szénatomosalkenil-, 2-8 szénatomos alkinil-, aril- vagy heteroaril-csoport,amely 2 utóbbi 1-8 szénatomos alkiléncsoporton keresztül iskapcsolódhat; 3-8 szénatomos cikloalkilcsoport; vagy 1-8 szénatomosalkiléncsoporton keresztül kapcsolódó 3-8 szénatomoscikloalkilcsoport; R7 jelentése adott esetben helyettesített 1-8szénatomos alkil-, 2-8 szénatomos alkenil-, 2-8 szénatomos alkinil-,aril- vagy heteroaril-csoport, amely 2 utóbbi 1-8 szénatomosalkiléncsoporton keresztül is kapcsolódhat; 3-8 szénatomoscikloalkilcsoport vagy 1-8 szénatomos alkilén-csoporton keresztülkapcsolódó 3-8 szénatomos cikloalkil-csoport. R8 jelentése adottesetben helyettesített 1-8 szénatomos alkil-, 2-8 szénatomos alkenil-,2-8 szénatomos alkinil-, aril- vagy heteroaril-csoport, amely 2 utóbbi1-8 szénatomos alkiléncsoporton keresztül is kapcsolódhat; 3-8szénatomos cikloalkil-csoport; vagy 1-8 szénatomos alkilén-csoportonkeresztül kapcsolódó 3-8 szénatomos cikloalkil-csoport;
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10117184A DE10117184A1 (de) | 2001-04-05 | 2001-04-05 | Substituierte Imidazol[1,2-a]-pyridin-3-yl-amid- und -aminverbindungen |
PCT/EP2002/003796 WO2002080911A2 (de) | 2001-04-05 | 2002-04-05 | Verwendung substituierter imidazo[1,2-a]-pyridin-3-yl-amid- und imidazo[1,2-a]-pyridin-3-yl-aminverbindungen als arzneimittel zur behandlung von neurodegenerativen erkrankungen |
Publications (1)
Publication Number | Publication Date |
---|---|
HUP0400877A2 true HUP0400877A2 (hu) | 2004-08-30 |
Family
ID=7680631
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0400877A HUP0400877A2 (hu) | 2001-04-05 | 2002-04-05 | Helyettesített imidazo[1,2-a]piridin-3-il-amid- és imidazo[1,2-a]-piridin-3-il-amin-vegyületek felhasználása gyógyszerként és eljárás a vegyületek előállítására |
Country Status (9)
Country | Link |
---|---|
US (1) | US20040122044A1 (hu) |
EP (1) | EP1372644A2 (hu) |
JP (1) | JP2004531512A (hu) |
CA (1) | CA2442986A1 (hu) |
DE (1) | DE10117184A1 (hu) |
HU (1) | HUP0400877A2 (hu) |
MX (1) | MXPA03008894A (hu) |
PL (1) | PL366437A1 (hu) |
WO (1) | WO2002080911A2 (hu) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10310106A1 (de) | 2003-03-06 | 2004-09-16 | Grünenthal GmbH | Substituierte Pyridot [1,2-a]pyrimidin-Verbindungen |
DE102004021716A1 (de) * | 2004-04-30 | 2005-12-01 | Grünenthal GmbH | Substituierte Imidazo[1,2-a]pyridin-Verbindungen und Arzneimittel enthaltend substituierte Imidazo[1,2-a]pyridin-Verbindungen |
DE102004044884A1 (de) * | 2004-09-14 | 2006-05-24 | Grünenthal GmbH | Substituierte bizyklische Imidazo-3-yl-amin-Verbindungen |
MX2008008152A (es) | 2005-12-23 | 2008-09-12 | Ariad Pharma Inc | Compuestos heterociclicos biciclicos. |
FR2903107B1 (fr) | 2006-07-03 | 2008-08-22 | Sanofi Aventis Sa | Derives d'imidazopyridine-2-carboxamides, leur preparation et leur application en therapeutique |
FR2903108B1 (fr) * | 2006-07-03 | 2008-08-29 | Sanofi Aventis Sa | Utilisation de derives d'imidazo[1,2-a] pyridine-2-carboxamides en therapeutique. |
FR2903105A1 (fr) | 2006-07-03 | 2008-01-04 | Sanofi Aventis Sa | Derives de 2-benzoyl-imidazopyridines, leur preparation et leur application en therapeutique |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4096264A (en) * | 1975-12-09 | 1978-06-20 | Merck & Co., Inc. | Certain substituted imidazo [1,2-a] pyridines |
US4105767A (en) * | 1977-03-28 | 1978-08-08 | Merck & Co., Inc. | Imidazo [1,2-a] pyridines substituted with a thienyl, thiazolyl, or thiadiazolyl group |
CA1164459A (en) * | 1980-11-11 | 1984-03-27 | Yung-Hsiung Yang | Process for preparing (imidazo¬1,2-a|pyridine- 2-yl)-carbostyril or -3,4-dihydrocarbostyryl derivatives |
DE3269604D1 (en) * | 1981-06-26 | 1986-04-10 | Schering Corp | Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them |
FR2638161B1 (fr) * | 1988-10-24 | 1991-01-11 | Centre Nat Rech Scient | Nouvelles benzoyl-2 imidazo (1,2-a) pyridines et leurs sels, leur procede de preparation, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant |
DK0471236T3 (da) * | 1990-07-30 | 1995-07-24 | Takeda Chemical Industries Ltd | Imidazopyridinderivater og deres anvendelse |
DE4405378A1 (de) * | 1994-02-19 | 1995-08-24 | Merck Patent Gmbh | Adhäsionsrezeptor-Antagonisten |
AU4859596A (en) * | 1995-02-15 | 1996-09-04 | Pharmacia & Upjohn Company | Imidazo{1,2-a}pyridines for the treatment of cns and cardiac diseases |
WO1996034866A1 (en) * | 1995-05-01 | 1996-11-07 | Fujisawa Pharmaceutical Co., Ltd. | Imidazo 1,2-a pyridine and imidazo 1,2-a pyridezine derivatives and their use as bone resorption inhibitors |
US5912256A (en) * | 1996-06-20 | 1999-06-15 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
US6013654A (en) * | 1997-08-14 | 2000-01-11 | Pharmacia & Upjohn Company | Imidazo[1,2-A]pyridines for the treatment of CNS and cardiac diseases |
DE19948437A1 (de) * | 1999-10-08 | 2001-06-07 | Gruenenthal Gmbh | Am Sechsring substituierte, bicyclische Imidazo-3-aminderivate |
DE19948438B4 (de) * | 1999-10-08 | 2004-04-15 | Grünenthal GmbH | Bicyclische Imidazo-3-aminderivate |
DE19948434A1 (de) * | 1999-10-08 | 2001-06-07 | Gruenenthal Gmbh | Substanzbibliothek enthaltend bicyclische Imidazo-5-amine und/oder bicyclische Imidazo-3-amine |
AU2001270297A1 (en) * | 2000-06-30 | 2002-01-14 | Neurogen Corporation | 2-phenylimidazo(1,2-a)pyridine derivatives: a new class of gaba brain receptor ligands |
DE10050663A1 (de) * | 2000-10-13 | 2002-04-18 | Gruenenthal Gmbh | Verwendung von substituierten Imidazo[1,2-a]pyridin-, -pyrimidin- und pyrazin-3-yl-amin-Derivaten zur Herstellung von Medikamenten zur NOS-Inhibierung |
-
2001
- 2001-04-05 DE DE10117184A patent/DE10117184A1/de not_active Withdrawn
-
2002
- 2002-04-05 WO PCT/EP2002/003796 patent/WO2002080911A2/de not_active Application Discontinuation
- 2002-04-05 JP JP2002578950A patent/JP2004531512A/ja not_active Withdrawn
- 2002-04-05 MX MXPA03008894A patent/MXPA03008894A/es unknown
- 2002-04-05 EP EP02730112A patent/EP1372644A2/de not_active Withdrawn
- 2002-04-05 PL PL02366437A patent/PL366437A1/xx not_active Application Discontinuation
- 2002-04-05 CA CA002442986A patent/CA2442986A1/en not_active Abandoned
- 2002-04-05 HU HU0400877A patent/HUP0400877A2/hu unknown
-
2003
- 2003-10-03 US US10/677,960 patent/US20040122044A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
PL366437A1 (en) | 2005-01-24 |
DE10117184A1 (de) | 2002-10-17 |
CA2442986A1 (en) | 2002-10-17 |
MXPA03008894A (es) | 2003-12-08 |
EP1372644A2 (de) | 2004-01-02 |
WO2002080911A3 (de) | 2003-09-25 |
JP2004531512A (ja) | 2004-10-14 |
WO2002080911A2 (de) | 2002-10-17 |
US20040122044A1 (en) | 2004-06-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0401302A2 (hu) | Helyettesített imidazo[1,2-a]piridin-vegyületek felhasználása gyógyszerként | |
TW200637869A (en) | The spiroketal derivatives and the use as therapeutical agent for diabetes of the same | |
MY145603A (en) | 2-ARYL-6-PHENYLIMIDAZO[1,2-a]PYRIDINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF | |
HK1068334A1 (en) | Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligands of the adenosine a2a receptor and their use as medicaments | |
HUP0402310A2 (hu) | 1,6-Naftiridin-származékok mint antidiabetikumok és ezeket tartalmazó gyógyszerkészítmények | |
BRPI0507984B8 (pt) | composto ou um sal do mesmo, processo para produzir um composto, medicamento, métodos para antagonizar angiotensina ii em um mamífero, para melhorar a resistência de insulina em um mamífero e para prevenir ou tratar doenças circulatórias em um mamífero, e, uso do composto | |
IL192253A0 (en) | Substituted cyclohexylmethyl derivatives | |
IL158343A (en) | Dopamine glycoconjugate compounds, pharmaceutical compositions comprising them, processes for their preparation and use thereof in the manufacture of medicaments and as medicaments for treating parkinson's disease | |
NZ533666A (en) | Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands | |
HUP0400877A2 (hu) | Helyettesített imidazo[1,2-a]piridin-3-il-amid- és imidazo[1,2-a]-piridin-3-il-amin-vegyületek felhasználása gyógyszerként és eljárás a vegyületek előállítására | |
WO2003082861A3 (en) | Morpholinyl-urea derivatives for use of the treatment of inflammatory diseases | |
MXPA04000407A (es) | Derivados de fenilacetamido-tiazol, procedimiento para su preparacion y uso como agentes antitumorales. | |
GB0205688D0 (en) | Chemical compounds | |
ATE514698T1 (de) | Tetracyclische azapyrazinoindoline als 5-ht2- liganden | |
GEP20115240B (en) | Indole derivatives, process for their preparation and pharmaceutical compositions containing them | |
NO20053805L (no) | Diarylmetylindenpiperidinderivater, framgangsmate for fremstilling derav, og anvendelse derav | |
EP1908755A4 (en) | THERAPEUTIC AGENT AGAINST RESTENOSIS | |
HUP0402584A2 (hu) | Új benzotiazin- és benzotiadiazin-vegyületek, előállításuk, és ezeket tartalmazó gyógyászati készítmények | |
HUP0301884A2 (hu) | Szubsztituált 1-amino-5-fenil-pentán-3-ol- és/vagy 1-amino-6-fenil-hexán-3-ol-származékok gyógyszerként történż alkalmazása | |
MXPA06000892A (es) | Compuestos azapoliciclicos arilo fusionados. | |
TW200510312A (en) | Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof | |
CA2515730A1 (en) | Pyrrolidinohydrochinazolines | |
HUP0402658A2 (hu) | Variolinszármazékok és ezeket tartalmazó daganatellenes gyógyászati készítmények | |
TW200510313A (en) | Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof | |
MXPA05013717A (es) | Derivados de acido 2-etoxi-2-fenilpropionico para el tratamiento de trastornos de lipido. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |